Vantage Consulting Group Inc Fibrogen Inc Transaction History
Vantage Consulting Group Inc
- $7.71 Million
- Q3 2024
A detailed history of Vantage Consulting Group Inc transactions in Fibrogen Inc stock. As of the latest transaction made, Vantage Consulting Group Inc holds 195,707 shares of FGEN stock, worth $68,497. This represents 1.01% of its overall portfolio holdings.
Number of Shares
195,707
Previous 195,707
-0.0%
Holding current value
$68,497
Previous $174,000
55.17%
% of portfolio
1.01%
Previous 0.28%
Shares
5 transactions
Others Institutions Holding FGEN
# of Institutions
82Shares Held
47.1MCall Options Held
387KPut Options Held
672K-
Primecap Management CO Pasadena, CA9.91MShares$3.47 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.8MShares$2.38 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.88MShares$2.06 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$1.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$843,3770.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $32.8M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...